MARK JEROME PYKETT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARK JEROME PYKETT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK JEROME PYKETT. MARK JEROME PYKETT is a EVP in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and a Pres. & CEO in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB).
Address: 425 METRO PLACE NORTH SUITE 300 DUBLIN 43017 OH
Companies in which MARK JEROME PYKETT is an Insider
NAVIDEA BIOPHARMACEUTICALS, INC.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of MARK JEROME PYKETT: Pres. & CEO, EVP
Holdings: 303,300 shares
Current Value: $157,716
Latest Transaction: Feb 22 2012
$NAVB Market Capitalization: $77.59M
$NAVB Previous Close: $0.52
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MARK JEROME PYKETT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22 2012 | NAVB | NAVIDEA BIOPHARMAC ... | PYKETT MARK JEROME | Pres. & CEO | Option Exercise | A | 3.28 | 250,000 | 820,000 | 250,000 | |
| Feb 22 2012 | NAVB | NAVIDEA BIOPHARMAC ... | PYKETT MARK JEROME | Pres. & CEO | Grant | A | 0.00 | 300,000 | 0 | 303,300 | 3.3 K to 303.3 K (+9,090.91 %) |
| Aug 23 2011 | NAVB | NAVIDEA BIOPHARMAC ... | PYKETT MARK JEROME | Pres. & CEO | Buy | P | 2.56 | 1,100 | 2,816 | 1,100 | 0 to 1.1 K |
| Aug 23 2011 | NAVB | NAVIDEA BIOPHARMAC ... | PYKETT MARK JEROME | Pres. & CEO | Buy | P | 2.56 | 100 | 256 | 3,300 | 3.2 K to 3.3 K (+3.13 %) |
| Aug 23 2011 | NAVB | NAVIDEA BIOPHARMAC ... | PYKETT MARK JEROME | Pres. & CEO | Buy | P | 2.60 | 500 | 1,300 | 3,200 | 2.7 K to 3.2 K (+18.52 %) |
| Aug 23 2011 | NAVB | NAVIDEA BIOPHARMAC ... | PYKETT MARK JEROME | Pres. & CEO | Buy | P | 2.61 | 2,700 | 7,047 | 2,700 | 0 to 2.7 K |
| Nov 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | PYKETT MARK JEROME | EVP | Option Exercise | A | 1.70 | 200,000 | 340,000 | 200,000 |